Methocarbamol 500 mg Tablets — Generic For Robaxin — Ascend

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Methocarbamol Tablets, USP are available in 500 mg and 750 mg strengths. The label describes methocarbamol as a central nervous system depressant with sedative and musculoskeletal relaxant properties.

It is indicated as an adjunct to rest, physical therapy, and other measures for relief of discomfort associated with acute, painful musculoskeletal conditions. The label states that its mode of action has not been clearly identified and that it does not directly relax tense skeletal muscles in humans.

Important label warnings include possible drowsiness, dizziness, and impaired ability to drive or operate machinery. The label also warns about combined effects with alcohol and other central nervous system depressants and says methocarbamol should not be used in women who are or may become pregnant unless the potential benefits outweigh the possible hazards.

Storage Information

Store at 20°– 25°C (68°– 77°F) [See USP Controlled Room Temperature]. DISPENSE in a tight container STORE at 20 to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

Key Counseling Points

• This medicine is used along with rest, physical therapy, and other measures for relief of discomfort from acute, painful musculoskeletal conditions.
• Methocarbamol may cause drowsiness or dizziness.
• Be cautious with driving or operating machinery until you know how this medicine affects you.
• Alcohol and other central nervous system depressants can add to the effects of methocarbamol.
• Tell a healthcare professional about all medicines you take, including drugs used for myasthenia gravis such as pyridostigmine bromide.
• The label says methocarbamol should not be used in women who are or may become pregnant unless the potential benefits outweigh the possible hazards.
• Use caution if breastfeeding, since it is not known whether methocarbamol or its metabolites are excreted in human milk.
• Safety and effectiveness in pediatric patients below age 16 have not been established.
• Seek medical help for signs of overdose such as nausea, drowsiness, blurred vision, hypotension, seizures, or coma.

Helpful Patient Education

Methocarbamol Tablets, USP are a prescription medicine available in 500 mg and 750 mg strengths. The DailyMed label describes methocarbamol as a central nervous system depressant with sedative and musculoskeletal relaxant properties, used as an adjunct to rest, physical therapy, and other measures for relief of discomfort associated with acute, painful musculoskeletal conditions.

Product labeling also warns that methocarbamol may cause drowsiness or dizziness and may add to the effects of alcohol and other central nervous system depressants. This educational product information is based on the DailyMed label and is intended to support safe, label-based understanding of the medication.

Medication Summary last generated: 2026-07-19 02:40:03